PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Aclidinium bromide/formoterol in COPD: Added benefit for certain patient groups

Added benefit is not proven for more severely ill patients

2015-05-12
(Press-News.org) The fixed-dose combination aclidinium bromide/formoterol has been approved since November 2014 for long-term treatment of adults with chronic obstructive pulmonary disease (COPD). The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether this drug combination offers an added benefit over the appropriate comparator therapy.

According to the findings, there is an indication of minor added benefit for adult patients with moderate COPD (grade II). For adults with grade III and fewer than 2 exacerbations (flare-ups) per year, there is proof of considerable added benefit versus the comparator therapy. In contrast, no conclusions can be drawn on greater or lesser benefit for more severely ill patients from the data presented.

Comparator therapy depends on severity and frequency of exacerbations

The Federal Joint Committee (G-BA) specified different appropriate comparator therapies depending on the severity of the disease: From a moderate severity grade (research question 1), the new drug combination was to be compared with a long-acting beta-2 sympathomimetic (such as formoterol) and/or tiotropium. From grade III and at least two flare-ups per year (research question 2), the patients in the comparator arm were to receive additional inhaled corticosteroid.

Three suitable studies with direct comparisons

The drug manufacturer submitted data from three double-blind, randomized controlled approval studies with patients with moderate to severe COPD, in which the drug combination was directly compared with formoterol. In contrast to the G-BA's specifications, all patients included in these studies could continue ongoing treatment with an inhaled corticosteroid, irrespective of their severity grade and the frequency of exacerbations. However, only the data of those patients who were treated in accordance with the G-BA's specifications were included in the analyses presented.

Relevant differences only in the E-RS symptom questionnaire

For patients with COPD grade IV, no evaluable data were available to answer research question 2; for grade III, the differences between the treatment groups were not statistically significant. Hence an added benefit for grade III or IV patients with at least two flare-ups per year is not proven.

Better data were available for research question 1. When asked about their dyspnoea, patients with grade III reported less dyspnoea under the new drug combination than under the control intervention. The difference was too small, however, to derive an added benefit from it.

When symptoms were recorded on a broader basis with the E-RS questionnaire (breathlessness, cough and sputum, chest symptoms), there was an indication of an added benefit for grade II, and proof of an added benefit for grade III. In addition, there was an indication of an added benefit in grade III for the outcome "severe exacerbations". For COPD grade IV patients, there were also no data for research question 1.

In summary, there is an indication of a minor added benefit for patients with moderate severity and proof of a considerable added benefit for patients with COPD grade III and no more than one flare-up per year.

INFORMATION:

G-BA decides on the extent of added benefit

This dossier assessment is part of the early benefit assessment according to the Act on the Reform of the Market for Medicinal Products (AMNOG) supervised by the G-BA. After publication of the dossier assessment, the G-BA conducts a commenting procedure and makes a final decision on the extent of the added benefit.

An overview of the results of IQWiG's benefit assessment is given by a German-language executive summary. In addition, the website » http://www.gesundheitsinformation.de, published by IQWiG, provides easily understandable German-language information on aclidinium bromide/formoterol.

More English-language information will be available soon (Sections 2.1 to 2.6 of the dossier assessment as well as subsequently published health information on » http://www.informedhealthonline.org). If you would like to be informed when these documents are available, please send an e-mail to » info@iqwig.de.



ELSE PRESS RELEASES FROM THIS DATE:

Gender difference in vital cell count of HIV patients

2015-05-12
Male HIV patients in rural South Africa reach the low immunity levels required to become eligible for antiretroviral treatment in less than half the time it takes for immunity levels to drop to similar levels in women, according to new research from the University of Southampton. Researchers also found a link between potential proxy measures of nutritional status and disease progression, with those reporting food shortages and use of nutritional supplements reaching lower levels of immunity faster. CD4 cell count is a measure of the immune system which indicates the ...

Quantum 'gruyères' for spintronics of the future

2015-05-12
They are 'strange' materials, insulators on the inside and conductors on the surface. They also have properties that make them excellent candidates for the development of spintronics ('spin-based electronics') and more in general quantum computing. However, they are also elusive as their properties are extremely difficult to observe. Now a SISSA study, published in Physical Review Letters, proposes a new family of materials whose topological state can be directly observed experimentally, thus simplifying things for researchers. "What interests us of topological insulators ...

A gap year does not weaken study success

2015-05-12
A gap year between high school and the start of university studies does not weaken young people's enthusiasm to study or their overall performance once the studies have commenced. On the other hand, adolescents who continue to university studies directly after upper secondary school are more resilient in their studies and more committed to the study goals. However, young people who transfer directly to university are more stressed than those who start their studies after a gap year. These research results have been achieved in the Academy of Finland's research programme ...

Malaria testing yet to reach its potential

2015-05-12
In a study published this month in Malaria Journal, researchers from Uppsala University and other institutions present a new model for systematically evaluating new malaria treatment programs in routine conditions across multiple countries. Despite major investments in malaria rapid diagnostic tests (RDT) in recent years, there remains limited evidence of their impact on treatment decisions in routine program conditions. Evidence to date is largely derived from small-scale facility studies conducted within a limited number of countries, notably Kenya, Malawi, Tanzania, ...

Six times more expensive to travel by car than by bicycle: Study

2015-05-12
It is six times more expensive for society - and for you individually - if you travel by car instead of cycling. This has been shown in a Lund University study of Copenhagen, a city of cyclists. It is the first time a price has been put on car use as compared to cycling. In the comparative study, Stefan Gössling from Lund University and Andy S. Choi from the University of Queensland have investigated a cost-benefit analysis that the Copenhagen Municipality uses to determine whether new cycling infrastructure should be built. It considers how much cars cost society ...

Alcohol treatment programs prove effective in cutting reoffending, study shows

2015-05-12
Offenders enrolled in alcohol treatment programmes as part of their sentence are significantly less likely to be charged or reconvicted in the 12 months following their programme, a study led by Plymouth University has shown. Researchers from the University's School of Psychology led a project, supported by the European Social Fund, which saw males with alcohol problems related to offending being assigned to a range of different treatments when convicted. They then calculated the participants' charged and reconviction rates over the following year, with the results ...

Significant progress made towards individualized cancer immunotherapy

Significant progress made towards individualized cancer immunotherapy
2015-05-12
This news release is available in German. Mainz-based researchers have made significant advances with regard to the development of individualized immunotherapy strategies for treating cancer. They have managed to identify the relevant genetic changes or mutations associated with various types of cancer and have determined their individual blueprints. This makes it possible for the scientists to readily produce customized cancer vaccines of the kind that have already been demonstrated to be effective in animal models. Here they have proven effective in the regression ...

Bragging: Researchers find self-promotion often backfires

2015-05-12
PITTSBURGH--Bragging to coworkers about a recent promotion, or posting a photo of your brand new car on Facebook, may seem like harmless ways to share good news. However, a new study from City University London, Carnegie Mellon University and Bocconi University shows that self-promotion or a "humblebrag" often backfires. Published in Psychological Science, Irene Scopelliti, George Loewenstein and Joachim Vosgerau wanted to find out why so many people frequently get the trade-off between self-promotion and modesty wrong. They found that self-promoters overestimate how ...

Mining pollution alters fish genetics in southwest England

Mining pollution alters fish genetics in southwest England
2015-05-12
Pollution from historic mining activities in south west England has led to a reduction in genetic diversity of brown trout according to new research from the University of Exeter. The findings, which will be published on Friday 15 May in the journal Evolutionary Applications, indicate that human activity can alter the genetic patterns of wild populations - an important issue in modern conservation. The prevalence of metal contaminants in rivers across the south west of England is directly linked to mining activities dating back hundreds of years. Exposure to high concentrations ...

More severe weather in store for middle states in US

More severe weather in store for middle states in US
2015-05-12
Today's imagery from NASA's AIRS instrument on the Aqua satellite indicates more severe weather is in store for the Midwest from Texas to Michigan. There is another extremely strong storm that is stretching from south to north and into Canada, and that system can be seen in this AIRS image from May 11, 2015. The first image (left) was taken at 3:35 am EDT, by the time the second image (right) was taken at 2:41 pm EDT the system had come together and was stretching across the nation vertically across the country. Current weather forecasting predicts that Monday evening ...

LAST 30 PRESS RELEASES:

‘Ding-dong:’ A study finds specific neurons with an immune doorbell

A major advance in biology combines DNA and RNA and could revolutionize cancer treatments

Neutrophil elastase as a predictor of delivery in pregnant women with preterm labor

NIH to lead implementation of National Plan to End Parkinson’s Act

Growth of private equity and hospital consolidation in primary care and price implications

Online advertising of compounded glucagon-like peptide-1 receptor agonists

Health care utilization and costs for older adults aging into Medicare after the affordable care act

Reading the genome and understanding evolution: Symbioses and gene transfer in leaf beetles

Brains of people with sickle cell disease appear older

Elena Belova and Yevgeny Raitses recognized for groundbreaking plasma physics research

SOX9 overexpression ameliorates metabolic dysfunction-associated steatohepatitis through activation of the AMPK pathway

Florescent probes illuminate cholesterol and Alzheimer’s research

Qigong significantly decreases chronic low back pain in US military veterans

New insights into pancreatic disease and diabetes

Effectiveness and safety of tenofovir amibufenamide in the treatment of chronic hepatitis B: A real-world, multicenter study

Higher costs limit attendance for life changing cardiac rehab

Over 500 patients receive diagnosis through genetic reanalysis

Brain changes in Huntington’s disease decades before diagnosis will guide future prevention trials

U of A astronomers capture unprecedented view of supermassive black hole in action

Astrophysicists reveal structure of 74 exocomet belts orbiting nearby stars in landmark survey

Textbooks need to be rewritten: RNA, not DNA, is the main cause of acute sunburn

Brits still associate working-class accents with criminal behavior – study warns of bias in the criminal justice system

What do you think ‘guilty’ sounds like? Scientists find accent stereotypes influence beliefs about who commits crimes

University of Calgary nursing study envisions child trauma treatment through a Marvel and DC lens

Research on performance optimization of virtual data space across WAN

Researchers reveal novel mechanism for intrinsic regulation of sugar cravings

Immunological face of megakaryocytes

Calorie labelling leads to modest reductions in selection and consumption

The effectiveness of intradialytic parenteral nutrition with ENEFLUID???? infusion

New study reveals AI’s transformative impact on ICU care with smarter predictions and transparent insights

[Press-News.org] Aclidinium bromide/formoterol in COPD: Added benefit for certain patient groups
Added benefit is not proven for more severely ill patients